SOUL: A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Sponsor
Novo Nordisk A/S (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT03914326
Collaborator
(none)
9,642
445
2
61.4
21.7
0.4
Study Details
Study Description
Brief Summary
The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or placebo tablets ("dummy" medicine) - which treatment is decided by chance. Participants must take one tablet with water every morning on an empty stomach and not eat or drink anything for at least 30 minutes. The study will last for about 3.5-5 years. Participants will have up to 25 clinic visits and 1 phone call with the study doctor. Women cannot be in the study if pregnant, breast-feeding or if they plan to become pregnant during the study period.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 3 |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
9642 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
Sponsor staff involved in the clinical trial is masked according to company standard procedures
Primary Purpose:
Treatment
Official Title:
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
Actual Study Start Date
:
Jun 17, 2019
Anticipated Primary Completion Date
:
Jul 29, 2024
Anticipated Study Completion Date
:
Jul 29, 2024
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Oral semaglutide One tablet daily for 3.5 to 5 years |
Drug: Semaglutide
Increasing doses (3 mg/7 mg/14 mg) of semaglutide tablets to be taken with water at the same time every morning in a fasting state
|
| Placebo Comparator: Placebo One tablet daily for 3.5 to 5 years |
Drug: Placebo (semaglutide)
Placebo tablets to be taken with water at the same time every morning in a fasting state
|
Outcome Measures
Primary Outcome Measures
- Time to first occurrence of a major adverse cardiovascular event (MACE), a composite endpoint consisting of: cardiovascular (CV) death/non-fatal myocardial infarction/non-fatal stroke [From randomisation (week 0) to end-of-trial (up to 61 months or more) (trial is event driven)]
Months
Secondary Outcome Measures
- Time to first occurrence of a composite endpoint [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Time to first occurrence of a composite endpoint consisting of: CV death/renal death/onset of persistent 50% or more reduction in estimated glomerular filtration rate (eGFR) (chronic kidney disease - epidemiology collaboration (CKD-EPI)) (compared with baseline)/onset of persistent eGFR (CKD-EPI) below 15 mL/min/1.73 m^2/initiation of chronic renal replacement therapy (dialysis or kidney transplantation). Unit of assessment: Months
- Time to occurrence of CV death [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of major adverse limb events (MALE), a composite endpoint consisting of: acute limb ischemia hospitalisation/chronic limb ischemia hospitalisation [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of an expanded MACE composite endpoint consisting of: CV death/non-fatal myocardial infarction/ non-fatal stroke/coronary revascularisation/unstable angina requiring hospitalisation [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of a composite heart failure endpoint consisting of: CV death/heart failure requiring hospitalisation/urgent heart failure visit [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of a composite CKD endpoint [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Time to first occurrence of a composite CKD endpoint consisting of: renal death/onset of persistent 50% or more reduction in eGFR (CKD-EPI)/onset of persistent eGFR (CKD-EPI) below 15 mL/min/1.73 m^2/initiation of chronic renal replacement therapy (dialysis or kidney transplantation). Unit of assessment: Months
- Time to occurrence of all-cause death [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of non-fatal myocardial infarction (MI) [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of non-fatal stroke [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of heart failure requiring hospitalisation [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of urgent heart failure visit [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of coronary revascularisation [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of unstable angina requiring hospitalisation [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to occurrence of renal death [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of onset of persistent 50% or more reduction in eGFR [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of onset of persistent eGFR (CKD-EPI) below 15 mL/min/1.73 m^2 [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of initiation of chronic renal replacement therapy (dialysis or kidney transplantation) [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of a composite endpoint consisting of: all-cause death/non-fatal myocardial infarction/non-fatal stroke [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of acute limb ischemia [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Time to first occurrence of chronic limb ischemia [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
- Annual rate of change in eGFR (CKD-EPI) (total eGFR slope) [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
ml/min/1.73 m^2 per year
- Change in glycosylated haemoglobin (HbA1c) [From randomisation (week 0) to 2 years]
Percent points
- Change in body weight [From randomisation (week 0) to 2 years]
Kilograms
- Number of severe hypoglycaemic episodes [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Number of events
- Time to first occurrence of a severe hypoglycaemic episode [From randomisation (week 0) to end-of-trial (up to 61 months or more)]
Months
Eligibility Criteria
Criteria
Ages Eligible for Study:
50 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Male or female, age equal to or above 50 years at the time of signing informed consent
-
Diagnosed with type 2 diabetes mellitus
-
HbA1c 6.5% - 10.0% (47 - 86 mmol/mol) (both inclusive) (latest available and no more than 30 days old local laboratory assessment based on medical records or point of care measurement)
-
At least one of the below conditions (a-d):
- Coronary heart disease defined as at least one of the following: i. Prior myocardial infarction ii. Prior coronary revascularisation procedure iii. 50% or above stenosis in coronary artery documented by cardiac catheterisation, computerized tomography coronary angiography iv. Coronary heart disease with ischaemia documented by stress test with any imaging modality b) Cerebrovascular disease defined as at least one of the following: i. Prior stroke ii. Prior carotid artery revascularisation procedure iii.50% or above stenosis in carotid artery documented by X-ray angiography, magnetic resonance angiography, computerized tomography angiography or Doppler ultrasound c) Symptomatic peripheral artery disease (PAD) defined as at least one of the following: i. Intermittent claudication with an Ankle-brachial index (ABI) below 0.85 at rest ii. Intermittent claudication with a 50% or above stenosis in peripheral artery (excluding carotid) documented by X-ray angiography, magnetic resonance angiography, computerized tomography angiography or Doppler ultrasound iii. Prior peripheral artery (excluding carotid) revascularization procedure iv. Lower extremity amputation at or above ankle due to atherosclerotic disease (excluding e.g. trauma or osteomyelitis) d) Chronic kidney disease defined as: i. eGFR below 60 mL/min/1.73 m^2 (based on medical records using latest available and no more than 6 months old assessment)
Exclusion Criteria:
-
Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening
-
Planned coronary, carotid or peripheral artery revascularisation known on the day of screening
-
Heart failure presently classified as being in New York Heart Association Class IV
-
Treatment with any glucagon-like peptide-1 receptor agonist within 30 days before screening
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Novo Nordisk Investigational Site | Montgomery | Alabama | United States | 36106 |
| 2 | Novo Nordisk Investigational Site | Little Rock | Arkansas | United States | 72211 |
| 3 | Novo Nordisk Investigational Site | Searcy | Arkansas | United States | 72143 |
| 4 | Novo Nordisk Investigational Site | Fresno | California | United States | 93721-1443 |
| 5 | Novo Nordisk Investigational Site | La Jolla | California | United States | 92037 |
| 6 | Novo Nordisk Investigational Site | La Mesa | California | United States | 91942 |
| 7 | Novo Nordisk Investigational Site | Lancaster | California | United States | 93534 |
| 8 | Novo Nordisk Investigational Site | Los Alamitos | California | United States | 90720 |
| 9 | Novo Nordisk Investigational Site | Mission Hills | California | United States | 91345 |
| 10 | Novo Nordisk Investigational Site | Monterey | California | United States | 93940 |
| 11 | Novo Nordisk Investigational Site | Palm Springs | California | United States | 92262 |
| 12 | Novo Nordisk Investigational Site | San Diego | California | United States | 92111 |
| 13 | Novo Nordisk Investigational Site | Torrance | California | United States | 90502 |
| 14 | Novo Nordisk Investigational Site | Ventura | California | United States | 93003 |
| 15 | Novo Nordisk Investigational Site | Aurora | Colorado | United States | 80045 |
| 16 | Novo Nordisk Investigational Site | Denver | Colorado | United States | 80246 |
| 17 | Novo Nordisk Investigational Site | Golden | Colorado | United States | 80401 |
| 18 | Novo Nordisk Investigational Site | Boca Raton | Florida | United States | 33433 |
| 19 | Novo Nordisk Investigational Site | New Port Richey | Florida | United States | 34652 |
| 20 | Novo Nordisk Investigational Site | Orlando | Florida | United States | 32804 |
| 21 | Novo Nordisk Investigational Site | Alpharetta | Georgia | United States | 30022 |
| 22 | Novo Nordisk Investigational Site | Lawrenceville | Georgia | United States | 30046 |
| 23 | Novo Nordisk Investigational Site | Roswell | Georgia | United States | 30076 |
| 24 | Novo Nordisk Investigational Site | Honolulu | Hawaii | United States | 96814 |
| 25 | Novo Nordisk Investigational Site | Idaho Falls | Idaho | United States | 83404-7596 |
| 26 | Novo Nordisk Investigational Site | Gurnee | Illinois | United States | 60031 |
| 27 | Novo Nordisk Investigational Site | Franklin | Indiana | United States | 46131 |
| 28 | Novo Nordisk Investigational Site | Greenfield | Indiana | United States | 46140 |
| 29 | Novo Nordisk Investigational Site | Michigan City | Indiana | United States | 46360 |
| 30 | Novo Nordisk Investigational Site | Muncie | Indiana | United States | 47304 |
| 31 | Novo Nordisk Investigational Site | West Des Moines | Iowa | United States | 50265 |
| 32 | Novo Nordisk Investigational Site | Lexington | Kentucky | United States | 40503 |
| 33 | Novo Nordisk Investigational Site | Louisville | Kentucky | United States | 40206 |
| 34 | Novo Nordisk Investigational Site | Louisville | Kentucky | United States | 40213 |
| 35 | Novo Nordisk Investigational Site | New Orleans | Louisiana | United States | 70112 |
| 36 | Novo Nordisk Investigational Site | Slidell | Louisiana | United States | 70461-4231 |
| 37 | Novo Nordisk Investigational Site | Buckley | Michigan | United States | 49620 |
| 38 | Novo Nordisk Investigational Site | Omaha | Nebraska | United States | 68114 |
| 39 | Novo Nordisk Investigational Site | Omaha | Nebraska | United States | 68198-3020 |
| 40 | Novo Nordisk Investigational Site | Las Vegas | Nevada | United States | 89128 |
| 41 | Novo Nordisk Investigational Site | Lebanon | New Hampshire | United States | 03756 |
| 42 | Novo Nordisk Investigational Site | Nashua | New Hampshire | United States | 03060 |
| 43 | Novo Nordisk Investigational Site | Albany | New York | United States | 12203 |
| 44 | Novo Nordisk Investigational Site | West Seneca | New York | United States | 14224 |
| 45 | Novo Nordisk Investigational Site | Westfield | New York | United States | 14787 |
| 46 | Novo Nordisk Investigational Site | Asheville | North Carolina | United States | 28803 |
| 47 | Novo Nordisk Investigational Site | Burlington | North Carolina | United States | 27215 |
| 48 | Novo Nordisk Investigational Site | Chapel Hill | North Carolina | United States | 27514 |
| 49 | Novo Nordisk Investigational Site | Greenville | North Carolina | United States | 27834 |
| 50 | Novo Nordisk Investigational Site | New Bern | North Carolina | United States | 28562 |
| 51 | Novo Nordisk Investigational Site | Whiteville | North Carolina | United States | 28472 |
| 52 | Novo Nordisk Investigational Site | Wilmington | North Carolina | United States | 28401 |
| 53 | Novo Nordisk Investigational Site | Fargo | North Dakota | United States | 58104 |
| 54 | Novo Nordisk Investigational Site | Marion | Ohio | United States | 43302 |
| 55 | Novo Nordisk Investigational Site | Maumee | Ohio | United States | 43537 |
| 56 | Novo Nordisk Investigational Site | Mentor | Ohio | United States | 44060 |
| 57 | Novo Nordisk Investigational Site | Twinsburg | Ohio | United States | 44087 |
| 58 | Novo Nordisk Investigational Site | Norman | Oklahoma | United States | 73072 |
| 59 | Novo Nordisk Investigational Site | Beaver | Pennsylvania | United States | 15009 |
| 60 | Novo Nordisk Investigational Site | McMurray | Pennsylvania | United States | 15317 |
| 61 | Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | United States | 19114 |
| 62 | Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | United States | 15243 |
| 63 | Novo Nordisk Investigational Site | Murrells Inlet | South Carolina | United States | 29576 |
| 64 | Novo Nordisk Investigational Site | Myrtle Beach | South Carolina | United States | 29572 |
| 65 | Novo Nordisk Investigational Site | Spartanburg | South Carolina | United States | 29303 |
| 66 | Novo Nordisk Investigational Site | Chattanooga | Tennessee | United States | 37404 |
| 67 | Novo Nordisk Investigational Site | Chattanooga | Tennessee | United States | 37411 |
| 68 | Novo Nordisk Investigational Site | Kingsport | Tennessee | United States | 37660 |
| 69 | Novo Nordisk Investigational Site | Nashville | Tennessee | United States | 37203 |
| 70 | Novo Nordisk Investigational Site | Nashville | Tennessee | United States | 37212 |
| 71 | Novo Nordisk Investigational Site | Tullahoma | Tennessee | United States | 37388 |
| 72 | Novo Nordisk Investigational Site | Arlington | Texas | United States | 76012-4637 |
| 73 | Novo Nordisk Investigational Site | Austin | Texas | United States | 78705 |
| 74 | Novo Nordisk Investigational Site | Austin | Texas | United States | 78731 |
| 75 | Novo Nordisk Investigational Site | Austin | Texas | United States | 78749 |
| 76 | Novo Nordisk Investigational Site | Dallas | Texas | United States | 75230 |
| 77 | Novo Nordisk Investigational Site | Dallas | Texas | United States | 75390-9302 |
| 78 | Novo Nordisk Investigational Site | Fort Worth | Texas | United States | 76132 |
| 79 | Novo Nordisk Investigational Site | Houston | Texas | United States | 77024 |
| 80 | Novo Nordisk Investigational Site | Houston | Texas | United States | 77061 |
| 81 | Novo Nordisk Investigational Site | Longview | Texas | United States | 75605 |
| 82 | Novo Nordisk Investigational Site | Midland | Texas | United States | 79707 |
| 83 | Novo Nordisk Investigational Site | Round Rock | Texas | United States | 78681 |
| 84 | Novo Nordisk Investigational Site | Sugar Land | Texas | United States | 77478 |
| 85 | Novo Nordisk Investigational Site | Waco | Texas | United States | 76708 |
| 86 | Novo Nordisk Investigational Site | South Burlington | Vermont | United States | 05403 |
| 87 | Novo Nordisk Investigational Site | Richmond | Virginia | United States | 23219 |
| 88 | Novo Nordisk Investigational Site | Winchester | Virginia | United States | 22601-3834 |
| 89 | Novo Nordisk Investigational Site | Kenosha | Wisconsin | United States | 60031 |
| 90 | Novo Nordisk Investigational Site | Algiers | Algeria | 16000 | |
| 91 | Novo Nordisk Investigational Site | Constantine | Algeria | 25000 | |
| 92 | Novo Nordisk Investigational Site | Oran | Algeria | 31000 | |
| 93 | Novo Nordisk Investigational Site | Setif | Algeria | 19000 | |
| 94 | Novo Nordisk Investigational Site | Buenos Aires | Argentina | B1704ETD | |
| 95 | Novo Nordisk Investigational Site | Buenos Aires | Argentina | B6000BHA | |
| 96 | Novo Nordisk Investigational Site | Buenos Aires | Argentina | C1181ACH | |
| 97 | Novo Nordisk Investigational Site | Capital Federal | Argentina | C1056ABJ | |
| 98 | Novo Nordisk Investigational Site | Cordoba | Argentina | 5000 | |
| 99 | Novo Nordisk Investigational Site | Córdoba | Argentina | 5008 | |
| 100 | Novo Nordisk Investigational Site | Córdoba | Argentina | X5003DCE | |
| 101 | Novo Nordisk Investigational Site | Córdoba | Argentina | X5006IKK | |
| 102 | Novo Nordisk Investigational Site | Lanus Este | Argentina | B1824KAJ | |
| 103 | Novo Nordisk Investigational Site | Mar del Plata | Argentina | B7600FZN | |
| 104 | Novo Nordisk Investigational Site | Rosario, Santa Fe | Argentina | S2000CVB | |
| 105 | Novo Nordisk Investigational Site | Graz | Austria | 8036 | |
| 106 | Novo Nordisk Investigational Site | Innsbruck | Austria | 6020 | |
| 107 | Novo Nordisk Investigational Site | Saint Stefan | Austria | 8511 | |
| 108 | Novo Nordisk Investigational Site | Wien | Austria | 1130 | |
| 109 | Novo Nordisk Investigational Site | Wien | Austria | 1160 | |
| 110 | Novo Nordisk Investigational Site | Bonheiden | Belgium | 2820 | |
| 111 | Novo Nordisk Investigational Site | Edegem | Belgium | 2650 | |
| 112 | Novo Nordisk Investigational Site | Gent | Belgium | 9000 | |
| 113 | Novo Nordisk Investigational Site | Kortrijk | Belgium | 8500 | |
| 114 | Novo Nordisk Investigational Site | Leuven | Belgium | 3000 | |
| 115 | Novo Nordisk Investigational Site | Roeselare | Belgium | 8800 | |
| 116 | Novo Nordisk Investigational Site | Brasilia | Distrito Federal | Brazil | 70390-700 |
| 117 | Novo Nordisk Investigational Site | Curitiba | Parana | Brazil | 80030-480 |
| 118 | Novo Nordisk Investigational Site | Curitiba | Parana | Brazil | 80045-170 |
| 119 | Novo Nordisk Investigational Site | Passo Fundo | Rio Grande Do Sul | Brazil | 99010-080 |
| 120 | Novo Nordisk Investigational Site | Campinas | Sao Paulo | Brazil | 13010-001 |
| 121 | Novo Nordisk Investigational Site | Campinas | Sao Paulo | Brazil | 13060-080 |
| 122 | Novo Nordisk Investigational Site | São Paulo | Sao Paulo | Brazil | 01223-001 |
| 123 | Novo Nordisk Investigational Site | São Paulo | Sao Paulo | Brazil | 01228-000 |
| 124 | Novo Nordisk Investigational Site | São Paulo | Sao Paulo | Brazil | 01228-200 |
| 125 | Novo Nordisk Investigational Site | Calgary | Alberta | Canada | T2V 4J2 |
| 126 | Novo Nordisk Investigational Site | Vancouver | British Columbia | Canada | V5Z 1M9 |
| 127 | Novo Nordisk Investigational Site | Halifax | Nova Scotia | Canada | B3H 1V7 |
| 128 | Novo Nordisk Investigational Site | Barrie | Ontario | Canada | L4N 7L3 |
| 129 | Novo Nordisk Investigational Site | Brampton | Ontario | Canada | L6S 0C6 |
| 130 | Novo Nordisk Investigational Site | Brampton | Ontario | Canada | L6T 0G1 |
| 131 | Novo Nordisk Investigational Site | Concord | Ontario | Canada | L4K 4M2 |
| 132 | Novo Nordisk Investigational Site | Hamilton | Ontario | Canada | L8M 1K7 |
| 133 | Novo Nordisk Investigational Site | Hamilton | Ontario | Canada | L8N 3Z5 |
| 134 | Novo Nordisk Investigational Site | Markham | Ontario | Canada | L3P 7P2 |
| 135 | Novo Nordisk Investigational Site | Sarnia | Ontario | Canada | N7T 4X3 |
| 136 | Novo Nordisk Investigational Site | Toronto | Ontario | Canada | M5B 1W8 |
| 137 | Novo Nordisk Investigational Site | Toronto | Ontario | Canada | M5G 2N2 |
| 138 | Novo Nordisk Investigational Site | Toronto | Ontario | Canada | M6G 1M2 |
| 139 | Novo Nordisk Investigational Site | Mirabel | Quebec | Canada | J7J 2K8 |
| 140 | Novo Nordisk Investigational Site | Montreal | Quebec | Canada | H4A 3T2 |
| 141 | Novo Nordisk Investigational Site | Quebec | Canada | G1V 4G2 | |
| 142 | Novo Nordisk Investigational Site | Beijing | Beijing | China | 100044 |
| 143 | Novo Nordisk Investigational Site | Cangzhou | Hebei | China | 061000 |
| 144 | Novo Nordisk Investigational Site | Changzhou | Jiangsu | China | 213003 |
| 145 | Novo Nordisk Investigational Site | Zhenjiang | Jiangsu | China | 212001 |
| 146 | Novo Nordisk Investigational Site | Jinan | Shandong | China | 250013 |
| 147 | Novo Nordisk Investigational Site | Shanghai | Shanghai | China | 200240 |
| 148 | Novo Nordisk Investigational Site | Barranquilla | Colombia | 80020 | |
| 149 | Novo Nordisk Investigational Site | Cali | Colombia | 760032 | |
| 150 | Novo Nordisk Investigational Site | Floridablanca | Colombia | 681004 | |
| 151 | Novo Nordisk Investigational Site | Pasto | Colombia | 520002 | |
| 152 | Novo Nordisk Investigational Site | Soledad | Colombia | 83001 | |
| 153 | Novo Nordisk Investigational Site | Krapinske Toplice | Croatia | 49217 | |
| 154 | Novo Nordisk Investigational Site | Osijek | Croatia | 31 000 | |
| 155 | Novo Nordisk Investigational Site | Pula | Croatia | 52100 | |
| 156 | Novo Nordisk Investigational Site | Rijeka | Croatia | 51000 | |
| 157 | Novo Nordisk Investigational Site | Split | Croatia | 21 000 | |
| 158 | Novo Nordisk Investigational Site | Varazdin | Croatia | 42 000 | |
| 159 | Novo Nordisk Investigational Site | Zadar | Croatia | 23000 | |
| 160 | Novo Nordisk Investigational Site | Zagreb | Croatia | 10 000 | |
| 161 | Novo Nordisk Investigational Site | Zagreb | Croatia | 10000 | |
| 162 | Novo Nordisk Investigational Site | Brno | Czechia | 656 91 | |
| 163 | Novo Nordisk Investigational Site | Chrudim | Czechia | 53701 | |
| 164 | Novo Nordisk Investigational Site | Hradec Kralove | Czechia | 500 05 | |
| 165 | Novo Nordisk Investigational Site | Moravska Ostrava | Czechia | 70200 | |
| 166 | Novo Nordisk Investigational Site | Ostrava | Czechia | 73000 | |
| 167 | Novo Nordisk Investigational Site | Plzen | Czechia | 30100 | |
| 168 | Novo Nordisk Investigational Site | Plzen | Czechia | 32600 | |
| 169 | Novo Nordisk Investigational Site | Plzeň | Czechia | 301 00 | |
| 170 | Novo Nordisk Investigational Site | Praha | Czechia | 14021 | |
| 171 | Novo Nordisk Investigational Site | Aarhus N | Denmark | 8200 | |
| 172 | Novo Nordisk Investigational Site | Hillerød | Denmark | 3400 | |
| 173 | Novo Nordisk Investigational Site | København | Denmark | 2400 | |
| 174 | Novo Nordisk Investigational Site | Slagelse | Denmark | 4200 | |
| 175 | Novo Nordisk Investigational Site | Svendborg | Denmark | 5700 | |
| 176 | Novo Nordisk Investigational Site | Besançon cedex | France | 25030 | |
| 177 | Novo Nordisk Investigational Site | DIJON cedex | France | 21079 | |
| 178 | Novo Nordisk Investigational Site | Le Coudray | France | 28630 | |
| 179 | Novo Nordisk Investigational Site | Marseille | France | 13005 | |
| 180 | Novo Nordisk Investigational Site | Narbonne | France | 11100 | |
| 181 | Novo Nordisk Investigational Site | Paris | France | 75877 | |
| 182 | Novo Nordisk Investigational Site | Pessac | France | 33600 | |
| 183 | Novo Nordisk Investigational Site | Strasbourg | France | 67098 | |
| 184 | Novo Nordisk Investigational Site | Dresden | Germany | 01277 | |
| 185 | Novo Nordisk Investigational Site | Dresden | Germany | 01307 | |
| 186 | Novo Nordisk Investigational Site | Essen | Germany | 45219 | |
| 187 | Novo Nordisk Investigational Site | Falkensee | Germany | 14612 | |
| 188 | Novo Nordisk Investigational Site | Hamburg | Germany | 21073 | |
| 189 | Novo Nordisk Investigational Site | Hamburg | Germany | 22041 | |
| 190 | Novo Nordisk Investigational Site | Jerichow | Germany | 39319 | |
| 191 | Novo Nordisk Investigational Site | Lingen | Germany | 49808 | |
| 192 | Novo Nordisk Investigational Site | Ludwigshafen | Germany | 67059 | |
| 193 | Novo Nordisk Investigational Site | Münster | Germany | 48145 | |
| 194 | Novo Nordisk Investigational Site | Oldenburg I. Holst | Germany | 23758 | |
| 195 | Novo Nordisk Investigational Site | Rehlingen-Siersburg | Germany | 66780 | |
| 196 | Novo Nordisk Investigational Site | Stuttgart | Germany | 70199 | |
| 197 | Novo Nordisk Investigational Site | Witten | Germany | 58455 | |
| 198 | Novo Nordisk Investigational Site | Shatin, New Territories | Hong Kong | 999077 | |
| 199 | Novo Nordisk Investigational Site | Hyderabad | Andhra Pradesh | India | 500034 |
| 200 | Novo Nordisk Investigational Site | Hyderabad | Andhra Pradesh | India | 500072 |
| 201 | Novo Nordisk Investigational Site | Secunderabad, | Andhra Pradesh | India | 500003 |
| 202 | Novo Nordisk Investigational Site | Guwahati | Assam | India | 781033 |
| 203 | Novo Nordisk Investigational Site | Ahmedabad | Gujarat | India | 380006 |
| 204 | Novo Nordisk Investigational Site | Ahmedabad | Gujarat | India | 380007 |
| 205 | Novo Nordisk Investigational Site | Rohtak | Haryana | India | 124001 |
| 206 | Novo Nordisk Investigational Site | Bangalore | Karnataka | India | 560054 |
| 207 | Novo Nordisk Investigational Site | Bangalore | Karnataka | India | 560092 |
| 208 | Novo Nordisk Investigational Site | Kozhikode | Kerala | India | 673017 |
| 209 | Novo Nordisk Investigational Site | Indore | Madhya Pradesh | India | 452010 |
| 210 | Novo Nordisk Investigational Site | Goa | Maharashtra | India | 403 202 |
| 211 | Novo Nordisk Investigational Site | Mumbai | Maharashtra | India | 4000016 |
| 212 | Novo Nordisk Investigational Site | Mumbai | Maharashtra | India | 400008 |
| 213 | Novo Nordisk Investigational Site | Mumbai | Maharashtra | India | 400058 |
| 214 | Novo Nordisk Investigational Site | Mumbai | Maharashtra | India | 400078 |
| 215 | Novo Nordisk Investigational Site | Pune | Maharashtra | India | 411021 |
| 216 | Novo Nordisk Investigational Site | Pune | Maharashtra | India | 411040 |
| 217 | Novo Nordisk Investigational Site | New Dehli | New Delhi | India | 110029 |
| 218 | Novo Nordisk Investigational Site | Bhubaneswar | Orissa | India | 751019 |
| 219 | Novo Nordisk Investigational Site | Ludhiana | Punjab | India | 141008 |
| 220 | Novo Nordisk Investigational Site | Mohali | Punjab | India | 160062 |
| 221 | Novo Nordisk Investigational Site | Jaipur | Rajasthan | India | 302006 |
| 222 | Novo Nordisk Investigational Site | Chennai | Tamil Nadu | India | 600086 |
| 223 | Novo Nordisk Investigational Site | Coimbatore | Tamil Nadu | India | 641018 |
| 224 | Novo Nordisk Investigational Site | Vellore | Tamil Nadu | India | 632004 |
| 225 | Novo Nordisk Investigational Site | Hyderabad | Telengana | India | 500003 |
| 226 | Novo Nordisk Investigational Site | Kolkata | West Bengal | India | 700020 |
| 227 | Novo Nordisk Investigational Site | Kolkata | West Bengal | India | 700054 |
| 228 | Novo Nordisk Investigational Site | Hyderabad | India | 500 012 | |
| 229 | Novo Nordisk Investigational Site | Ludhiana | India | 141001 | |
| 230 | Novo Nordisk Investigational Site | New Delhi | India | 110001 | |
| 231 | Novo Nordisk Investigational Site | New Delhi | India | 110085 | |
| 232 | Novo Nordisk Investigational Site | Thriruvananthapuram | India | 695 032 | |
| 233 | Novo Nordisk Investigational Site | Haifa | Israel | 31096 | |
| 234 | Novo Nordisk Investigational Site | Jerusalem | Israel | 91120 | |
| 235 | Novo Nordisk Investigational Site | Jerusalem | Israel | 93106 | |
| 236 | Novo Nordisk Investigational Site | Kfar Saba | Israel | 44281 | |
| 237 | Novo Nordisk Investigational Site | Nahariya | Israel | 22100 | |
| 238 | Novo Nordisk Investigational Site | Petah-Tikva | Israel | 49100 | |
| 239 | Novo Nordisk Investigational Site | Tel Hashomer | Israel | 52621 | |
| 240 | Novo Nordisk Investigational Site | Tel Hashomer | Israel | 5265601 | |
| 241 | Novo Nordisk Investigational Site | Tel-Aviv | Israel | 64239 | |
| 242 | Novo Nordisk Investigational Site | Bari | Italy | 70124 | |
| 243 | Novo Nordisk Investigational Site | Catanzaro | Italy | 88100 | |
| 244 | Novo Nordisk Investigational Site | Chieti | Italy | 66100 | |
| 245 | Novo Nordisk Investigational Site | Lucca | Italy | 55100 | |
| 246 | Novo Nordisk Investigational Site | Milano | Italy | 20132 | |
| 247 | Novo Nordisk Investigational Site | Milano | Italy | 20138 | |
| 248 | Novo Nordisk Investigational Site | Napoli | Italy | 80131 | |
| 249 | Novo Nordisk Investigational Site | Padova | Italy | 35128 | |
| 250 | Novo Nordisk Investigational Site | Palermo | Italy | 90127 | |
| 251 | Novo Nordisk Investigational Site | Palermo | Italy | 90129 | |
| 252 | Novo Nordisk Investigational Site | Perugia | Italy | 06129 | |
| 253 | Novo Nordisk Investigational Site | Roma | Italy | 00133 | |
| 254 | Novo Nordisk Investigational Site | Roma | Italy | 00161 | |
| 255 | Novo Nordisk Investigational Site | Bunkyo-ku, Tokyo | Japan | 113-8655 | |
| 256 | Novo Nordisk Investigational Site | Chiba | Japan | 271-0077 | |
| 257 | Novo Nordisk Investigational Site | Ehime | Japan | 790-0024 | |
| 258 | Novo Nordisk Investigational Site | Fukui | Japan | 910-0846 | |
| 259 | Novo Nordisk Investigational Site | Fukuoka | Japan | 816-0864 | |
| 260 | Novo Nordisk Investigational Site | Ibaraki | Japan | 311-0113 | |
| 261 | Novo Nordisk Investigational Site | Kumamoto | Japan | 862-0976 | |
| 262 | Novo Nordisk Investigational Site | Kyoto-shi, Kyoto | Japan | 606-8507 | |
| 263 | Novo Nordisk Investigational Site | Kyoto | Japan | 611-0041 | |
| 264 | Novo Nordisk Investigational Site | Miyagi | Japan | 983-0039 | |
| 265 | Novo Nordisk Investigational Site | Miyazaki | Japan | 880-0034 | |
| 266 | Novo Nordisk Investigational Site | Nagano | Japan | 390-8621 | |
| 267 | Novo Nordisk Investigational Site | Osaka | Japan | 564-0013 | |
| 268 | Novo Nordisk Investigational Site | Osaka | Japan | 565-0871 | |
| 269 | Novo Nordisk Investigational Site | Osaka | Japan | 569-1045 | |
| 270 | Novo Nordisk Investigational Site | Osaka | Japan | 574-0074 | |
| 271 | Novo Nordisk Investigational Site | Saga-shi, Saga | Japan | 849-8501 | |
| 272 | Novo Nordisk Investigational Site | Sapporo-shi, Hokkaido | Japan | 062-0003 | |
| 273 | Novo Nordisk Investigational Site | Takamatsu-shi, Kagawa | Japan | 760-8557 | |
| 274 | Novo Nordisk Investigational Site | Tochigi | Japan | 323-0022 | |
| 275 | Novo Nordisk Investigational Site | Tokorozawa-shi, Saitama | Japan | 356-1142 | |
| 276 | Novo Nordisk Investigational Site | Tokyo | Japan | 103-0027 | |
| 277 | Novo Nordisk Investigational Site | Tokyo | Japan | 113-8431 | |
| 278 | Novo Nordisk Investigational Site | Tokyo | Japan | 177-0041 | |
| 279 | Novo Nordisk Investigational Site | Tokyo | Japan | 192-0918 | |
| 280 | Novo Nordisk Investigational Site | Tokyo | Japan | 196-0003 | |
| 281 | Novo Nordisk Investigational Site | Gyeonggi-do | Korea, Republic of | 13620 | |
| 282 | Novo Nordisk Investigational Site | Gyeonggi-do | Korea, Republic of | 471-101 | |
| 283 | Novo Nordisk Investigational Site | Seoul | Korea, Republic of | 02841 | |
| 284 | Novo Nordisk Investigational Site | Seoul | Korea, Republic of | 03722 | |
| 285 | Novo Nordisk Investigational Site | Seoul | Korea, Republic of | 05505 | |
| 286 | Novo Nordisk Investigational Site | Seoul | Korea, Republic of | 06591 | |
| 287 | Novo Nordisk Investigational Site | Seoul | Korea, Republic of | 139-827 | |
| 288 | Novo Nordisk Investigational Site | Alor Setar | Malaysia | 05460 | |
| 289 | Novo Nordisk Investigational Site | Kota Bharu, Kelantan | Malaysia | 16150 | |
| 290 | Novo Nordisk Investigational Site | Kota Bharu | Malaysia | 15586 | |
| 291 | Novo Nordisk Investigational Site | Kota Samarahan | Malaysia | 94300 | |
| 292 | Novo Nordisk Investigational Site | Kuala Lumpur | Malaysia | 59100 | |
| 293 | Novo Nordisk Investigational Site | Kuching | Malaysia | 93586 | |
| 294 | Novo Nordisk Investigational Site | Putrajaya | Malaysia | 62250 | |
| 295 | Novo Nordisk Investigational Site | Sarawak | Malaysia | 98000 | |
| 296 | Novo Nordisk Investigational Site | Seremban | Malaysia | 70300 | |
| 297 | Novo Nordisk Investigational Site | Sungai Buloh | Malaysia | 47000 | |
| 298 | Novo Nordisk Investigational Site | Guadalajara | Jalisco | Mexico | 44600 |
| 299 | Novo Nordisk Investigational Site | Guadalajara | Jalisco | Mexico | 44650 |
| 300 | Novo Nordisk Investigational Site | Tlalpan | México, D.F. | Mexico | 14080 |
| 301 | Novo Nordisk Investigational Site | Monterrey | Nuevo León | Mexico | 64020 |
| 302 | Novo Nordisk Investigational Site | Monterrey | Nuevo León | Mexico | 64060 |
| 303 | Novo Nordisk Investigational Site | San Nicolas de los Garza | Nuevo León | Mexico | 66465 |
| 304 | Novo Nordisk Investigational Site | Hermosillo | Sonora | Mexico | 83280 |
| 305 | Novo Nordisk Investigational Site | Merida | Yucatan | Mexico | 97070 |
| 306 | Novo Nordisk Investigational Site | Mérida | Yucatan | Mexico | 97070 |
| 307 | Novo Nordisk Investigational Site | Aguascalientes | Mexico | 20230 | |
| 308 | Novo Nordisk Investigational Site | Amersfoort | Netherlands | 3813 TZ | |
| 309 | Novo Nordisk Investigational Site | Amsterdam | Netherlands | 1081 HV | |
| 310 | Novo Nordisk Investigational Site | Apeldoorn | Netherlands | 7334 DZ | |
| 311 | Novo Nordisk Investigational Site | Delft | Netherlands | 2625 AD | |
| 312 | Novo Nordisk Investigational Site | Eindhoven | Netherlands | 5631 BM | |
| 313 | Novo Nordisk Investigational Site | Groningen | Netherlands | 9728 NT | |
| 314 | Novo Nordisk Investigational Site | Hoogeveen | Netherlands | 7909 AA | |
| 315 | Novo Nordisk Investigational Site | Maastricht | Netherlands | 6229 HX | |
| 316 | Novo Nordisk Investigational Site | Nijmegen | Netherlands | 6525 GA | |
| 317 | Novo Nordisk Investigational Site | Utrecht | Netherlands | 3584 CX | |
| 318 | Novo Nordisk Investigational Site | Cluj Napoca | Cluj | Romania | 400006 |
| 319 | Novo Nordisk Investigational Site | Targoviste | Dambovita | Romania | 130086 |
| 320 | Novo Nordisk Investigational Site | Targu Mures | Mures | Romania | 540136 |
| 321 | Novo Nordisk Investigational Site | Tirgu Mures | Mures | Romania | 540142 |
| 322 | Novo Nordisk Investigational Site | Ploiesti | Prahova | Romania | 100018 |
| 323 | Novo Nordisk Investigational Site | Ploiesti | Prahova | Romania | 100342 |
| 324 | Novo Nordisk Investigational Site | Bacau | Romania | 600154 | |
| 325 | Novo Nordisk Investigational Site | Bucharest | Romania | 051811 | |
| 326 | Novo Nordisk Investigational Site | Galati | Romania | 800578 | |
| 327 | Novo Nordisk Investigational Site | Iasi | Romania | 700111 | |
| 328 | Novo Nordisk Investigational Site | Sibiu | Romania | 550371 | |
| 329 | Novo Nordisk Investigational Site | Barnaul | Russian Federation | 656045 | |
| 330 | Novo Nordisk Investigational Site | Kazan | Russian Federation | 420012 | |
| 331 | Novo Nordisk Investigational Site | Kazan | Russian Federation | 420111 | |
| 332 | Novo Nordisk Investigational Site | Kemerovo | Russian Federation | 650066 | |
| 333 | Novo Nordisk Investigational Site | Moscow | Russian Federation | 117292 | |
| 334 | Novo Nordisk Investigational Site | Moscow | Russian Federation | 119435 | |
| 335 | Novo Nordisk Investigational Site | Novosibirsk | Russian Federation | 630087 | |
| 336 | Novo Nordisk Investigational Site | Novosibirsk | Russian Federation | 630099 | |
| 337 | Novo Nordisk Investigational Site | Penza | Russian Federation | 440026 | |
| 338 | Novo Nordisk Investigational Site | Saint Petersburg | Russian Federation | 194156 | |
| 339 | Novo Nordisk Investigational Site | Saint-Petersburg | Russian Federation | 191119 | |
| 340 | Novo Nordisk Investigational Site | Saint-Petersburg | Russian Federation | 194354 | |
| 341 | Novo Nordisk Investigational Site | Saint-Petersburg | Russian Federation | 197110 | |
| 342 | Novo Nordisk Investigational Site | Saratov | Russian Federation | 410039 | |
| 343 | Novo Nordisk Investigational Site | Saratov | Russian Federation | 410053 | |
| 344 | Novo Nordisk Investigational Site | St. Petersburg | Russian Federation | 194354 | |
| 345 | Novo Nordisk Investigational Site | Tomsk | Russian Federation | 634050 | |
| 346 | Novo Nordisk Investigational Site | Tumen | Russian Federation | 625023 | |
| 347 | Novo Nordisk Investigational Site | Ulianovsk | Russian Federation | 432063 | |
| 348 | Novo Nordisk Investigational Site | Yaroslavl | Russian Federation | 150062 | |
| 349 | Novo Nordisk Investigational Site | Yoshkar-Ola | Russian Federation | 424004 | |
| 350 | Novo Nordisk Investigational Site | Belgrade | Serbia | 11000 | |
| 351 | Novo Nordisk Investigational Site | Kragujevac | Serbia | 34000 | |
| 352 | Novo Nordisk Investigational Site | Nis | Serbia | 18000 | |
| 353 | Novo Nordisk Investigational Site | Novi Sad | Serbia | 21000 | |
| 354 | Novo Nordisk Investigational Site | Zajecar | Serbia | 19000 | |
| 355 | Novo Nordisk Investigational Site | Bratislava | Slovakia | 831 01 | |
| 356 | Novo Nordisk Investigational Site | Bratislava | Slovakia | 83103 | |
| 357 | Novo Nordisk Investigational Site | Bratislava | Slovakia | 833 05 | |
| 358 | Novo Nordisk Investigational Site | Kosice | Slovakia | 040 01 | |
| 359 | Novo Nordisk Investigational Site | Kosice | Slovakia | 04022 | |
| 360 | Novo Nordisk Investigational Site | Krompachy | Slovakia | 05342 | |
| 361 | Novo Nordisk Investigational Site | Nitra | Slovakia | 949 01 | |
| 362 | Novo Nordisk Investigational Site | Poprad | Slovakia | 05801 | |
| 363 | Novo Nordisk Investigational Site | Prievidza | Slovakia | 97101 | |
| 364 | Novo Nordisk Investigational Site | Rimavska Sobota | Slovakia | 97901 | |
| 365 | Novo Nordisk Investigational Site | Roznava | Slovakia | 04801 | |
| 366 | Novo Nordisk Investigational Site | Vrutky | Slovakia | 038 61 | |
| 367 | Novo Nordisk Investigational Site | Benoni | Gauteng | South Africa | 1501 |
| 368 | Novo Nordisk Investigational Site | Johannesburg | Gauteng | South Africa | 1619 |
| 369 | Novo Nordisk Investigational Site | Johannesburg | Gauteng | South Africa | 1818 |
| 370 | Novo Nordisk Investigational Site | Johannesburg | Gauteng | South Africa | 1827 |
| 371 | Novo Nordisk Investigational Site | Johannesburg | Gauteng | South Africa | 1829 |
| 372 | Novo Nordisk Investigational Site | Johannesburg | Gauteng | South Africa | 2198 |
| 373 | Novo Nordisk Investigational Site | Pretoria | Gauteng | South Africa | 0083 |
| 374 | Novo Nordisk Investigational Site | Pretoria | Gauteng | South Africa | 0181 |
| 375 | Novo Nordisk Investigational Site | Berea | KwaZulu-Natal | South Africa | 4091 |
| 376 | Novo Nordisk Investigational Site | Durban | KwaZulu-Natal | South Africa | 4092 |
| 377 | Novo Nordisk Investigational Site | Durban | KwaZulu-Natal | South Africa | 4170 |
| 378 | Novo Nordisk Investigational Site | Durban | KwaZulu-Natal | South Africa | 4450 |
| 379 | Novo Nordisk Investigational Site | Cape Town | Western Cape | South Africa | 7925 |
| 380 | Novo Nordisk Investigational Site | Alcorcón | Spain | 28922 | |
| 381 | Novo Nordisk Investigational Site | Antequera | Spain | 29200 | |
| 382 | Novo Nordisk Investigational Site | Barcelona | Spain | 08003 | |
| 383 | Novo Nordisk Investigational Site | Burela | Spain | 27880 | |
| 384 | Novo Nordisk Investigational Site | Córdoba | Spain | 14004 | |
| 385 | Novo Nordisk Investigational Site | La Coruña | Spain | 15006 | |
| 386 | Novo Nordisk Investigational Site | Las Palmas de Gran Canaria | Spain | 35010 | |
| 387 | Novo Nordisk Investigational Site | Málaga | Spain | 29006 | |
| 388 | Novo Nordisk Investigational Site | Pozuelo de Alarcon | Spain | 28223 | |
| 389 | Novo Nordisk Investigational Site | Sanlúcar de Barrameda | Spain | 11540 | |
| 390 | Novo Nordisk Investigational Site | Santander | Spain | 39008 | |
| 391 | Novo Nordisk Investigational Site | Santiago de Compostela | Spain | 15706 | |
| 392 | Novo Nordisk Investigational Site | Sevilla | Spain | 41009 | |
| 393 | Novo Nordisk Investigational Site | Changhua City | Taiwan | 500 | |
| 394 | Novo Nordisk Investigational Site | Taichung City | Taiwan | 402 | |
| 395 | Novo Nordisk Investigational Site | Taoyuan city | Taiwan | 333 | |
| 396 | Novo Nordisk Investigational Site | Bangkoknoi, Bangkok | Thailand | 10700 | |
| 397 | Novo Nordisk Investigational Site | Bangkok | Thailand | 10330 | |
| 398 | Novo Nordisk Investigational Site | Bangkok | Thailand | 10400 | |
| 399 | Novo Nordisk Investigational Site | Bangkok | Thailand | 10700 | |
| 400 | Novo Nordisk Investigational Site | Chiang Mai | Thailand | 50200 | |
| 401 | Novo Nordisk Investigational Site | Nakhon Ratchasima | Thailand | 30000 | |
| 402 | Novo Nordisk Investigational Site | Adana | Turkey | 01000 | |
| 403 | Novo Nordisk Investigational Site | Ankara | Turkey | 06010 | |
| 404 | Novo Nordisk Investigational Site | Bursa | Turkey | 16310 | |
| 405 | Novo Nordisk Investigational Site | Erzurum | Turkey | 25240 | |
| 406 | Novo Nordisk Investigational Site | Eskisehir | Turkey | 26040 | |
| 407 | Novo Nordisk Investigational Site | Hatay | Turkey | 31060 | |
| 408 | Novo Nordisk Investigational Site | Istanbul | Turkey | 34096 | |
| 409 | Novo Nordisk Investigational Site | Istanbul | Turkey | 34303 | |
| 410 | Novo Nordisk Investigational Site | Istanbul | Turkey | 34722 | |
| 411 | Novo Nordisk Investigational Site | Izmir | Turkey | 35340 | |
| 412 | Novo Nordisk Investigational Site | Kayseri | Turkey | 38039 | |
| 413 | Novo Nordisk Investigational Site | Sivas | Turkey | 58140 | |
| 414 | Novo Nordisk Investigational Site | Trabzon | Turkey | 61080 | |
| 415 | Novo Nordisk Investigational Site | Cherkasy | Ukraine | 18009 | |
| 416 | Novo Nordisk Investigational Site | Chernivtsi | Ukraine | 58022 | |
| 417 | Novo Nordisk Investigational Site | Dnipro | Ukraine | 49005 | |
| 418 | Novo Nordisk Investigational Site | Kyiv | Ukraine | 03049 | |
| 419 | Novo Nordisk Investigational Site | Kyiv | Ukraine | 04053 | |
| 420 | Novo Nordisk Investigational Site | Lviv | Ukraine | 79010 | |
| 421 | Novo Nordisk Investigational Site | Odesa | Ukraine | 65025 | |
| 422 | Novo Nordisk Investigational Site | Poltava | Ukraine | 36039 | |
| 423 | Novo Nordisk Investigational Site | Uzhhorod | Ukraine | 88000 | |
| 424 | Novo Nordisk Investigational Site | Zhytomyr | Ukraine | 10002 | |
| 425 | Novo Nordisk Investigational Site | Aberdeen | United Kingdom | AB25 2ZD | |
| 426 | Novo Nordisk Investigational Site | Addlestone | United Kingdom | KT15 2BH | |
| 427 | Novo Nordisk Investigational Site | Belfast | United Kingdom | BT12 6BA | |
| 428 | Novo Nordisk Investigational Site | Bradford-on-Avon | United Kingdom | BA15 1DQ | |
| 429 | Novo Nordisk Investigational Site | Bristol | United Kingdom | BS10 5NB | |
| 430 | Novo Nordisk Investigational Site | Cambridge | United Kingdom | CB2 0QQ | |
| 431 | Novo Nordisk Investigational Site | Chippenham | United Kingdom | SN15 1HP | |
| 432 | Novo Nordisk Investigational Site | Coventry | United Kingdom | CV2 2DX | |
| 433 | Novo Nordisk Investigational Site | Edinburgh | United Kingdom | EH4 2XU | |
| 434 | Novo Nordisk Investigational Site | Glasgow | United Kingdom | G31 2ER | |
| 435 | Novo Nordisk Investigational Site | Glasgow | United Kingdom | G51 4TF | |
| 436 | Novo Nordisk Investigational Site | Harrogate | United Kingdom | HG2 7SX | |
| 437 | Novo Nordisk Investigational Site | Hinckley | United Kingdom | LE10 2SE | |
| 438 | Novo Nordisk Investigational Site | Hull | United Kingdom | HU3 2JZ | |
| 439 | Novo Nordisk Investigational Site | London | United Kingdom | NW3 2QG | |
| 440 | Novo Nordisk Investigational Site | Manchester | United Kingdom | M8 5RB | |
| 441 | Novo Nordisk Investigational Site | Norfolk | United Kingdom | NR4 7UQ | |
| 442 | Novo Nordisk Investigational Site | Plymouth | United Kingdom | PL6 8DH | |
| 443 | Novo Nordisk Investigational Site | Redhill | United Kingdom | RH1 5RH | |
| 444 | Novo Nordisk Investigational Site | Soham | United Kingdom | CB7 5JD | |
| 445 | Novo Nordisk Investigational Site | Swansea | United Kingdom | SA2 8PP |
Sponsors and Collaborators
- Novo Nordisk A/S
Investigators
- Study Director: Clinical Reporting Anchor and Disclosure (1452), Novo Nordisk A/S
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT03914326
Other Study ID Numbers:
- EX9924-4473
- 2018-003141-42
- U1111-1218-5368
First Posted:
Apr 16, 2019
Last Update Posted:
Mar 14, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: